PMID- 19167831 OWN - NLM STAT- MEDLINE DCOM- 20090825 LR - 20211020 IS - 1873-3360 (Electronic) IS - 0306-4530 (Print) IS - 0306-4530 (Linking) VI - 34 IP - 6 DP - 2009 Jul TI - A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. PG - 815-21 LID - 10.1016/j.psyneuen.2008.12.010 [doi] AB - There is emerging evidence from healthy individuals, as well as direct and indirect evidence from psychiatric and neurological patients with disease-related hippocampal atrophy, linking the cortisol awakening response (CAR) to hippocampal volume. Type 2 diabetes mellitus (T2DM) is a metabolic disease that is also accompanied by hippocampal atrophy, and therefore can serve as a model for ascertaining the relationship between CAR and hippocampal volume. We contrasted a group of 18 individuals with T2DM with 12 matched controls on MRI-based hippocampal volume and salivary diurnal cortisol profile including CAR. Individuals with T2DM had smaller hippocampal volumes and exhibited a blunting of the CAR relative to controls, while diurnal cortisol was not affected. Across all subjects, fasting insulin and hippocampal volume were associated with the CAR, independent of diagnosis. Our findings support the hypothesis that hippocampal integrity is an important predictor of the CAR. FAU - Bruehl, Hannah AU - Bruehl H AD - NYU School of Medicine, Department of Psychiatry, New York, NY 10016, USA. FAU - Wolf, Oliver T AU - Wolf OT FAU - Convit, Antonio AU - Convit A LA - eng GR - M01 RR000096/RR/NCRR NIH HHS/United States GR - DK 064087/DK/NIDDK NIH HHS/United States GR - P30 AG008051/AG/NIA NIH HHS/United States GR - R01 DK064087/DK/NIDDK NIH HHS/United States GR - M01 RR00096/RR/NCRR NIH HHS/United States GR - P30-AG-08051/AG/NIA NIH HHS/United States GR - R01 DK064087-05/DK/NIDDK NIH HHS/United States GR - M01 RR000096-47/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20090124 PL - England TA - Psychoneuroendocrinology JT - Psychoneuroendocrinology JID - 7612148 RN - WI4X0X7BPJ (Hydrocortisone) SB - IM MH - Aged MH - Arousal/*physiology MH - Atrophy/complications MH - Brain/pathology MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*complications/*metabolism/pathology/physiopathology MH - Female MH - Hippocampus/*pathology MH - Humans MH - Hydrocortisone/analysis/*metabolism MH - Male MH - Middle Aged MH - Organ Size MH - Saliva/chemistry/metabolism PMC - PMC2774914 MID - NIHMS114160 COIS- Conflict of interest The authors have no real or apparent conflict of interest. EDAT- 2009/01/27 09:00 MHDA- 2009/08/26 09:00 PMCR- 2009/11/09 CRDT- 2009/01/27 09:00 PHST- 2008/08/20 00:00 [received] PHST- 2008/10/24 00:00 [revised] PHST- 2008/12/16 00:00 [accepted] PHST- 2009/01/27 09:00 [entrez] PHST- 2009/01/27 09:00 [pubmed] PHST- 2009/08/26 09:00 [medline] PHST- 2009/11/09 00:00 [pmc-release] AID - S0306-4530(08)00337-5 [pii] AID - 10.1016/j.psyneuen.2008.12.010 [doi] PST - ppublish SO - Psychoneuroendocrinology. 2009 Jul;34(6):815-21. doi: 10.1016/j.psyneuen.2008.12.010. Epub 2009 Jan 24.